Tweets
When would I use
#Aclasta vs #Prolia since #denosumab has LESS #fractures
▶️younger women with #osteoporosis requiring Rx due to long safety
▶️less wearing off when stopping it
▶️noncompliant Pts as prolia reverses effect when dose is missed
@RheumNow #EULAR2024 @eular_org https://t.co/0RTGx0sCTd
Janet Pope @Janetbirdope ( View Tweet )
1 year 10 months ago
Agree!
Liz Volkmann said it straight
Unsustainable RCTs in ILD trials in #scleroderma
Why
Can’t recruit
~same pool of early #dcSSc design RCT
UNETHICAL a to have a progressing #scleroderma-ILD Pt on failed background #MMF + placebo for 1 yr
🙏🏻 #EULAR2024 @RheumNow @eular_org https://t.co/29oFEazwmM
Janet Pope @Janetbirdope ( View Tweet )
1 year 10 months ago
I think if we’re worried about JAK inhibitor safety, we need to be doing it right.
I wrote this for @RheumNow for #EULAR2024 ahead of my debate against @Janetbirdope, but also drew my inspiration from @RADoctor in @ACR_Journals - a must read:
https://t.co/RA6ktQAzqO https://t.co/lltDbtxpAg
Links:
David Liew @drdavidliew ( View Tweet )
1 year 10 months ago
🗓️ Our abstract on psychosocial determinants of health in #RheumatoidArthritis will be presented at #EULAR2024
📹 Watch my video on @RheumNow for a sneak preview!
📍 Join me to hear more on #PARE Poster Tour IV, Friday 14th June, 12:00 - 13:00 CEST
https://t.co/rDTJVukD6j
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
➡️POS0591 Are there sex differences in risk & outcomes of stroke in patients with #RA?
📈Stroke risk in RA increased compared to general population
🫀Not fully explained by traditional risk factors or AF
📊Stroke-related mortality differs in women vs men
@RheumNow #EULAR2024
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
POS0592 Increased overall & cause-specific mortality in population-based cohort of people with incident #RA
Higher mortality in RA vs gen pop but this has decreased after 2000 & better 10-year survival
Severe causes of mortality incl cardiac higher in RA
EULAR2024 @RheumNow
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
POS1035 FVC & risk of lung transplant & mortality in #RAILD
50% pts had FVC % predicted decline in ~6.5yrs
2/3 identified groups more strongly assoc w transplant or ILD-related death than INBUILD definition ➡️marked heterogeneity in ILD progression
#EULAR2024 @RheumNow
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 10 months ago
#EULAR2024 POS1245 Healthcare Administrative Data in Italy showed despite prevalence of 3.8/10,000, heathcare cost in #Sjogren was 3 x higher than the general population due to active disease & comorbidities. Call for better MDT approach in management @RheumNow https://t.co/EevoT4jkqr
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 10 months ago
important session worth reading the full recommendations - TNF tick of approval @RheumNow #EULAR2024 https://t.co/ORDocVie11
Peter Nash @drpnash ( View Tweet )
1 year 10 months ago
#EULAR2024 POS1420 A cohort study with 1/3 each with GCA, PMR and GCA+PMR found that at 6mth, 16% of patients had new diabetes/diabetes worsened. Worse in GCA+PMR group with the greatest GC accumulation. Call for better GC-sparing strategy @RheumNow https://t.co/ex7u83bVfj
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 10 months ago
#EULAR2024 POS0742 A single cohort study showed for non-criteria #APS, cardiac manifestation (valvular dysfunction & regurgitation) was more common in Triple Ab+ vs Non-Triple Ab. We should monitor and consider an echocardiogram for this group of patient @RheumNow https://t.co/VxFUSpjaG1
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 10 months ago
Active day of learning and discussion with a Round Up from Day 3 of #EULAR2024 with @RheumNow https://t.co/yzLsPNDM5d
Dr. Antoni Chan @synovialjoints ( View Tweet )
1 year 10 months ago
